RecruitingNot ApplicableNCT05899920

Clinical One-stage Controlled Study of reSistant Arterial Hypertension for the desiGning of a personAlized Approach to Therapy


Sponsor

Ryazan State Medical University

Enrollment

190 participants

Start Date

Mar 11, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

This study was planned to assess the concentration of antihypertensive drugs in the blood plasma in patients with controlled and uncontrolled arterial hypertension. Methods: it is planned to include patients with arterial hypertension taking 3 antihypertensive drugs (indapanide, lisinopril or valsartan, amlodipine). Based on the results of 24-hour blood pressure monitoring, the patients will be randomized into two groups: The first group - the patients with controlled AH; The second group - the patients with uncontrolled AH. Venous blood was taken in both groups of the patients in the morning before and 2 hours after taking drugs to assess the concentration of lisinopril, amlodipine, valsartan and indapamide. Concentation of assesed antihypertensive drugs will be compared in both groups.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is looking at whether a personalized approach to treating resistant high blood pressure — where standard medications haven't worked well enough — leads to better blood pressure control. It involves testing different combinations of blood pressure medications. **You may be eligible if...** - You have been diagnosed with high blood pressure according to established guidelines - You have already made lifestyle changes as recommended - You have been taking two blood pressure medications (lisinopril, amlodipine, or valsartan) combined with indapamide for at least one month at stable doses - If you are a woman of childbearing age, you are using reliable contraception throughout the study **You may NOT be eligible if...** - You are involved in running or organizing this study - You are pregnant Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTBlood samples will be taken for pharmacokinetics and pharmacogenetics

To assess antihypertensive drugs concentration (lisinopril, valsartan, amlodipine, indapamide


Locations(1)

Ryzan State Medical University

Ryazan, Russia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05899920


Related Trials